Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

Sen. Susan Collins and patient advocate Jill Feldman are recognized with AACR Distinguished Service Awards

The American Association for Cancer Research will honor leaders from government and the advocacy community with awards for distinguished service in support of cancer research at the AACR Annual Meeting 2026 to be held April 17-22 in San Diego.

April 17, 2026

Vol.52 No.15

Clinical Roundup

E-cigarette taxes reduce vaping; no increase in adult smoking, OSU study finds

For years, a central debate in tobacco policy has been whether taxing e-cigarettes might unintentionally drive vapers back to traditional cigarettes.

April 17, 2026

Vol.52 No.15

In Brief

VCU Massey–Sanford Burnham Prebys Drug Discovery Collaborative Program launches two projects

The VCU Massey Comprehensive Cancer Center completed the inaugural funding cycle of its VCU–Sanford Burnham Prebys Drug Discovery Collaborative Program, a collaboration with the Sanford Burnham Prebys Medical Discovery Institute in La Jolla, CA.

April 10, 2026

Vol.52 No.14

Clinical Roundup

Lung cancer surgery safe for many patients over 80, Mount Sinai study finds

Adults aged 80 and older with early-stage lung cancer can safely undergo surgery and achieve outcomes comparable to younger patients, challenging longstanding assumptions about age and cancer treatment, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center.

April 10, 2026

Vol.52 No.14

Clinical Roundup

Small molecule inhibitor blocks prostate cancer bone metastasis

Findings out of VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine, published in Pharmacological Research, show that a targeted small molecule inhibitor, IVMT-Rx-4, may prevent prostate tumors from spreading to an advanced and incurable stage in the bones.

April 03, 2026

Vol.52 No.13

In Brief

Lisa Roth named director of pediatric hematology-oncology at Hassenfeld Children’s Hospital at NYU Langone

Lisa G. Roth was named director of the Division of Pediatric Hematology-Oncology at Hassenfeld Children’s Hospital at NYU Langone and Perlmutter Cancer Center. Roth is a pediatric oncologist, physician-scientist, and lymphoma survivor.

March 27, 2026

Vol.52 No.12

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

YOU MAY BE INTERESTED IN

Sen. Susan Collins and patient advocate Jill Feldman are recognized with AACR Distinguished Service Awards

E-cigarette taxes reduce vaping; no increase in adult smoking, OSU study finds

VCU Massey–Sanford Burnham Prebys Drug Discovery Collaborative Program launches two projects

Lung cancer surgery safe for many patients over 80, Mount Sinai study finds

Small molecule inhibitor blocks prostate cancer bone metastasis

Lisa Roth named director of pediatric hematology-oncology at Hassenfeld Children’s Hospital at NYU Langone

Renew today!

Subscriber content

Never miss an issue!

Login